Clinical trial

Fimasartan Achieving SBP Target (FAST) Study

NCT02495324

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-06-01

PhasePHASE4

Study timeline

Study start (actual)2015-06-01Date precision: month

Registry last updated2017-07-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential,Hypertensionunresolved

Interventions

PlaceboDRUG

FimasartanDRUG

ValsartanDRUG · verified · RxNorm: valsartan

Olmesartan medoxomilDRUG · verified · RxNorm: olmesartan medoxomil

Sponsors & collaborators

Boryung Pharmaceutical Co., Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02495324 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.